These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 10797445

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents.
    Banker DE, Groudine M, Willman CL, Norwood T, Appelbaum FR.
    Leuk Res; 1998 Mar; 22(3):221-39. PubMed ID: 9619914
    [Abstract] [Full Text] [Related]

  • 3. Flow cytometric chemosensitivity analysis of blasts from patients with acute myeloblastic leukemia and myelodysplastic syndromes: the use of 7AAD with antibodies to CD45 or CD34.
    Pallis M, Syan J, Russell NH.
    Cytometry; 1999 Dec 01; 37(4):308-13. PubMed ID: 10547616
    [Abstract] [Full Text] [Related]

  • 4. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
    Rao J, Xu DR, Zheng FM, Long ZJ, Huang SS, Wu X, Zhou WH, Huang RW, Liu Q.
    J Transl Med; 2011 May 19; 9():71. PubMed ID: 21595920
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
    Olaru D, Campos L, Flandrin P, Nadal N, Duval A, Chautard S, Guyotat D.
    Cytometry B Clin Cytom; 2008 Jan 19; 74(1):17-24. PubMed ID: 18061947
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia.
    Lacombe F, Durrieu F, Briais A, Dumain P, Belloc F, Bascans E, Reiffers J, Boisseau MR, Bernard P.
    Leukemia; 1997 Nov 19; 11(11):1878-86. PubMed ID: 9369421
    [Abstract] [Full Text] [Related]

  • 10. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    Williams MS, Basma NJ, Amaral FMR, Wiseman DH, Somervaille TCP.
    BMC Cancer; 2021 Oct 28; 21(1):1153. PubMed ID: 34711181
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov 28; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 12. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L, Vidriales MB, García-Laraña J, Sanz G, Moreno MJ, López A, Barrena S, Martínez R, Tormo M, Palomera L, Lavilla E, López-Berges MC, de Santiago M, de Equiza ME, Miguel JF, Orfao A.
    Clin Cancer Res; 2004 Nov 15; 10(22):7599-606. PubMed ID: 15569991
    [Abstract] [Full Text] [Related]

  • 13. CD117/CD34 expression in leukemic blasts.
    Wells SJ, Bray RA, Stempora LL, Farhi DC.
    Am J Clin Pathol; 1996 Aug 15; 106(2):192-5. PubMed ID: 8712172
    [Abstract] [Full Text] [Related]

  • 14. Anti-Tumor and Immune Enhancing Activities of Rice Bran Gramisterol on Acute Myelogenous Leukemia.
    Somintara S, Leardkamolkarn V, Suttiarporn P, Mahatheeranont S.
    PLoS One; 2016 Aug 15; 11(1):e0146869. PubMed ID: 26752299
    [Abstract] [Full Text] [Related]

  • 15. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
    Hoffmann MH, Klausen TW, Boegsted M, Larsen SF, Schmitz A, Leinoe EB, Schmiegelow K, Hasle H, Bergmann OJ, Sorensen S, Nyegaard M, Dybkaer K, Johnsen HE.
    Cytometry B Clin Cytom; 2012 May 15; 82(3):123-31. PubMed ID: 22328535
    [Abstract] [Full Text] [Related]

  • 16. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
    Al-Mawali A, Gillis D, Hissaria P, Lewis I.
    Am J Clin Pathol; 2008 Jun 15; 129(6):934-45. PubMed ID: 18480011
    [Abstract] [Full Text] [Related]

  • 17. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
    Xu B, Hu C, Miao XD, Wu YH, Yi ZS, Yang Y, Meng FY, Feng R, Liu QF, Liu XL, Zheng WY.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct 15; 23(10):1043-6. PubMed ID: 14559689
    [Abstract] [Full Text] [Related]

  • 18. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A.
    Folia Med Cracov; 2001 Oct 15; 42(3):5-80. PubMed ID: 12353422
    [Abstract] [Full Text] [Related]

  • 19. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A, Gillis D, Lewis I.
    J Hematol Oncol; 2016 Jul 27; 9(1):61. PubMed ID: 27465508
    [Abstract] [Full Text] [Related]

  • 20. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007 Jul 27; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.